Senior Director, Operations Commercialization Lead (Cell Therapy) jobs in United States
info-icon
This job has closed.
company-logo

AstraZeneca · 2 days ago

Senior Director, Operations Commercialization Lead (Cell Therapy)

AstraZeneca is seeking a Senior Director, Operations Commercialization Lead to establish their global supply chain commercialization roadmap for cell therapy products. The role involves driving operational strategies, optimizing supply chain efficiency, and leading cross-functional teams to ensure successful product launches and lifecycle management.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits

Responsibilities

Lead formation and delivery of commercial supply strategic roadmap for cell therapy, ensuring seamless integration of supply with commercial operations
Align strategic programs with cross-functional partners to achieve mutual financial, service-level, and outcome-based goals
Represent Cell Therapy Operations on the Global Product Teams that commercialize and increase cell therapy products across the Oncology, Biopharm and Alexion departments
Partner with commercial and operations responsibilities to ensure strategies and operational plans foster innovation, efficiency, and shared success across the value chain
Be a main interface between the Commercial Business Units and the Cell Therapy Organization, aligning supply chain go-to-market plans with commercial and product strategy, including assessments and recommendations for investment decisions and market expansion business cases
Design, and increase end-to-end value chains for new products and throughout the product lifecycle, focusing on scalability, and regulatory compliance
Promote capability development with functional leaders, supporting supply chain, commercial operations goals, and financial goals
Lead commercial launch activities, aligning Product, Commercial, and Operations, to accomplish commercial launches
Lead end-to-end coordination of cross-functional teams to deliver launch success and global supply chain orchestration
Identify process gaps and risks across the supply chain, developing business continuity plans to avoid supply disruption

Qualification

Supply Chain ManagementCell Therapy ExperienceValue Chain DesignCross-Functional LeadershipStakeholder ManagementFinancial SkillsProject ManagementCommunication SkillsStrategic Thinking

Required

Bachelor's degree in life sciences, engineering, or supply chain required; advanced degree (MBA, MS)
14+ years of experience in biopharma operations, with at least 2 (two) years in advanced therapies (cell and gene therapy). 12+ years with advanced degree
Experience with autologous and allogeneic supply models and global supply chain management in the cell therapy, biologics, or pharmaceutical sector
A comprehensive understanding of product development, manufacturing and supply management within a matrixed environment
Understanding of global, regional and local environments to identify risks, and design supply chains
Experience in leadership of cross-functional teams for new product introduction and commercial launches
Mastery of value chain design, S&OP/IBP, procurement and logistics
Think, strategy development, project management, business case development, financial skills, product costing capabilities
Demonstrated proficiency in stakeholder management and executive-level communication to effectively influence senior leaders across the organization
Proven capability in leading cross-functional teams and navigating complex matrix organizational structures

Benefits

Benefits offered included a qualified retirement program [401(k) plan];
Paid vacation and holidays; paid leaves; and, health benefits including medical.
Prescription drug, dental, and vision coverage following the terms and conditions of the applicable plans.

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Chief Executive Officer
leader-logo
Aradhana Sarin
Group Chief Financial Officer and Executive Director
linkedin
Company data provided by crunchbase